Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.75% | 22.83% | 23.51% | 30.11% | 38.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.75% | 22.83% | 23.51% | 30.11% | 38.23% |
| Cost of Revenue | 40.08% | 46.87% | 57.21% | 73.09% | 101.00% |
| Gross Profit | 16.96% | 13.17% | 10.51% | 16.20% | 22.35% |
| SG&A Expenses | 11.75% | 12.67% | 15.45% | 4.47% | -5.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.55% | -2.88% | -1.81% | 18.76% | 48.82% |
| Total Operating Expenses | 12.68% | 13.86% | 16.81% | 18.07% | 19.41% |
| Operating Income | 20.55% | 11.24% | 0.64% | 8.35% | 15.24% |
| Income Before Tax | 19.82% | 9.47% | -2.26% | 29.69% | 47.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.82% | 9.47% | -2.26% | 24.42% | 40.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.82% | 9.47% | -2.26% | 24.42% | 40.83% |
| EBIT | 20.55% | 11.24% | 0.64% | 8.35% | 15.24% |
| EBITDA | 16.33% | 2.83% | -12.51% | 15.77% | 34.98% |
| EPS Basic | 34.52% | 25.09% | 15.92% | 40.63% | 53.93% |
| Normalized Basic EPS | 34.39% | 24.85% | 15.56% | 24.88% | 32.03% |
| EPS Diluted | 34.52% | 25.09% | 15.92% | 40.63% | 53.93% |
| Normalized Diluted EPS | 34.39% | 24.85% | 15.56% | 24.88% | 32.03% |
| Average Basic Shares Outstanding | 23.07% | 22.16% | 21.16% | 23.10% | 25.32% |
| Average Diluted Shares Outstanding | 23.07% | 22.16% | 21.16% | 23.10% | 25.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |